WASHINGTON – According to White House senior medical advisor Anthony Fauci, the US Food and Drug Administration (FDA) is likely to approve Pfizer's Covid vaccination for children under the age of five in February.

According to Fauci, younger children will likely require three doses because two shots did not produce a robust immune response in Pfizer's clinical studies among children aged 2-4 years.. "My hope is that it will be within the next month or two, and not much later than that," Fauci said, but he couldn't guarantee it.

Pfizer announced in December 2021 that if the three-dose study is successful, data will be submitted to the FDA in the first half of 2022.  The US pharmaceutical company stated there were no safety problems with the 3-microgram vaccine doses in youngsters aged six months to four years. As part of their primary round of immunizations, adults receive two doses of 30 micrograms each.

Children under the age of five are especially vulnerable at the moment because they are the only age group that is not already vaccinated. As the extremely contagious Omicron strain has swiftly spread across communities across the US over the last month, hospitalizations of children with Covid are on the rise.

Novavax: Australia's fifth approved COVID-19 vaccine

New study reveals, COVID19 vaccinations provide long-term protection.

New study reveals, COVID19 vaccinations provide long-term protection.